KT-474 (KYM-001) is an orally bioavailable PROTAC that targets IRAK4 for degradation and exhibits antitumor properties. It features an alkyne functional group, enabling it to participate in copper-catalyzed azide-alkyne cycloaddition, facilitating the formation of diverse molecular constructs.
Usually ships within 24 hours.